Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide is a research paper published in Clinical and Translational Science (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U2CES030158
National Institutes of Health
Grant: 5P30CA033572
National Institutes of Health
Grant: 5P30CA015704
National Institutes of Health
Grant: P01CA18029
National Institutes of Health
Grant: R01CA182963
National Institutes of Health
Grant: U01CA239373
National Institutes of Health
Grant: R01GM129863
NCI NIH HHS
Grant: P30 CA033572
NCI NIH HHS
Grant: P01 CA018029
NCI NIH HHS
Grant: P30 CA015704
National Institutes of Health
Grant: 3P30CA015704-42S2
Cancer Center Support Grant
National Institutes of Health
Grant: 3U2CES030158-03S1
West Coast Metabolomics Center for Compound Identification
National Institutes of Health
Grant: 5U01CA239373-02
Optimizing GVHD Prevention with Systems Pharmacology Models
National Institutes of Health
Grant: 1R01CA182963-01A1
Optimizing Busulfan: Efficacy, Toxicity, and Pharmacometabolomics
National Institutes of Health
Grant: 5P01CA018029-36
Targeting Alloreactivity for Leukemia Eradication
National Institutes of Health
Grant: 1R01GM129863-01
Cyclophosphamide Pharmacokinetics and Pharmacometabolomics
National Institutes of Health
Grant: 5P30CA033572-27
Developmental Funds
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals